Fear of childbirth, mental health, and medication use during pregnancy

被引:0
作者
Hedvig Nordeng
Cathrine Hansen
Susan Garthus-Niegel
Malin Eberhard-Gran
机构
[1] University of Oslo,Department of Pharmacy, School of Pharmacy
[2] Norwegian Institute of Public Health,Division of Mental Health
[3] Akershus University Hospital,Health Services Research Centre
[4] University of Oslo,Institute of Clinical Medicine
来源
Archives of Women's Mental Health | 2012年 / 15卷
关键词
Fear of childbirth; Medication use; Anxiety; Depression; Pregnancy;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this work was to study the associations between medication use, fear of childbirth, and maternal mental health. Pregnant women (n = 1,984) were recruited through routine antenatal care at a Norwegian hospital from November 2008 through April 2010. Data were collected by three self-completed questionnaires at pregnancy week 17 and 32 and at 8 weeks postpartum. Fear of childbirth was measured by the Wijma Delivery Expectancy Questionnaire (W-DEQ). Symptoms of anxiety were measured by the Hopkins Symptom Checklist (SCL-25) and symptoms of depression by the Edinburgh Postnatal Depression Scale (EPDS). In total, 57.7 % of the women used medications during pregnancy. Analgesics were used by 55.8 % of the women and psychotropic medications by 1.8 %. In all, 7.8 % of the women reported fear of childbirth (W-DEQ >85), the prevalence of anxiety (SCL >18) was 11.8 % and the prevalence of depression (EPDS >13) was 8.1 %. Fear of childbirth was significantly associated with use of psychotropic drugs (OR 3.63; 95 % CI 1.39–9.43) but not with the use of analgesics or medications in general. The presence of symptoms of anxiety or depression increased the magnitude of this association. Fear of childbirth is associated with an increased use of psychotropic medication. This finding could not only be explained by an overlap between fear of childbirth and impaired mental health.
引用
收藏
页码:203 / 209
页数:6
相关论文
共 121 条
[1]  
Bonari L(2004)Perinatal risks of untreated depression during pregnancy Can J Psychiatry 49 726-735
[2]  
Pinto N(1994)Factors related to drug consumption during pregnancy Acta Obstet Gynecol Scand 73 535-540
[3]  
Ahn E(2010)Medication use in early pregnancy—prevalence and determinants of use in a prospective cohort of women Pharmacoepidemiol Drug Saf 19 408-417
[4]  
Einarson A(1987)Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale Br J Psychiatry 150 782-786
[5]  
Steiner M(1996)Validation of the Edinburgh postnatal depression scale (EPDS) in non-postnatal women J Affect Disord 39 185-189
[6]  
Koren G(2000)Drug use in pregnancy among Italian women Eur J Clin Pharmacol 56 323-328
[7]  
Bonassi S(2001)The Edinburgh Postnatal Depression Scale: validation in a Norwegian community sample Nord J Psychiatry 55 113-117
[8]  
Magnani M(2010)A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction Arch Gen Psychiatry 67 1012-1024
[9]  
Calvi A(2009)Childbirth fear, anxiety, fatigue, and sleep deprivation in pregnant women J Obstet Gynecol Neonatal Nurs 38 567-576
[10]  
Repetto E(2006)Fear of childbirth and history of abuse: implications for pregnancy and delivery Acta Obstet Gynecol Scand 85 435-440